Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Patents
  • Published:

Building the proper foundation for genomics-based patents

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. In re Deuel. 43 U.S.P.Q.2d 1210 (Fed. Cir. 1995).

  2. Amgen v. Transkaryotic Therapies. Civil Action No. 97-10814-WGY (D of Mass, April 15, 1998).

  3. Amgen v. Chugai Pharmaceuticals . 18 U.S.P.Q.2d 1016 (Fed. Cir 1991).

  4. Genentech v. The Wellcome Foundation. 24 U.S.P.Q.2d 1782 1992).

  5. Genentech v. Novo Nordisk. 42 U.S.P.Q.2d 1001 (CA Fed. Cir. 1997).

  6. The Regents of the University of California v. Eli Lilly and Co. 43 U.S.P.Q.2d 1398 1997).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chahine, K. Building the proper foundation for genomics-based patents. Nat Biotechnol 16, 683–684 (1998). https://doi.org/10.1038/nbt0798-683

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0798-683

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing